A Pillar-Based High-Throughput Myogenic Differentiation Assay to Assess Drug Safety
High-throughput, pillar-strip-based assays have been proposed as a drug-safety screening tool for developmental toxicity. In the assay described here, muscle cell culture and differentiation were allowed to occur at the end of a pillar strip (eight pillars) compatible with commercially available 96-...
Main Authors: | Kyeong Hwan Ahn, Sooil Kim, Mihi Yang, Dong Woo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/19/5805 |
Similar Items
-
Platelet-poor plasma of athletes is a potent inducer of myogenic differentiation of C2C12 myoblasts
by: Maslovarić Irina S., et al.
Published: (2020-01-01) -
Extracellular xenogeneic hemoglobin suppresses the capacity for C2C12 myoblast myogenic differentiation
by: Stančić Ana Z., et al.
Published: (2020-01-01) -
Lidocaine Inhibits Myoblast Cell Migration and Myogenic Differentiation Through Activation of the Notch Pathway
by: Ling X, et al.
Published: (2021-03-01) -
Uncoupling Protein 3 Promotes the Myogenic Differentiation of Type IIb Myotubes in C2C12 Cells
by: Ziwei You, et al.
Published: (2023-11-01) -
Toxoplasma gondii Impairs Myogenesis in vitro, With Changes in Myogenic Regulatory Factors, Altered Host Cell Proliferation and Secretory Profile
by: Paloma de Carvalho Vieira, et al.
Published: (2019-11-01)